5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | NEUTRAL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.18▼ | 2.18▼ | 2.16▼ | 2.08▲ | 2.09▲ |
MA10 | 2.18▼ | 2.16▲ | 2.16▲ | 2.15▲ | 2.20▼ |
MA20 | 2.18▼ | 2.16▼ | 2.13▲ | 2.11▲ | 2.35▼ |
MA50 | 2.15▲ | 2.12▲ | 2.11▲ | 2.24▼ | 3.21▼ |
MA100 | 2.16▼ | 2.12▲ | 2.12▲ | 2.38▼ | 5.64▼ |
MA200 | 2.13▲ | 2.11▲ | 2.16▲ | 2.95▼ | 10.42▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.001▼ | 0.002▲ | 0.012▲ | 0.051▲ |
RSI | 45.764▼ | 52.441▲ | 55.239▲ | 49.948▼ | 43.772▼ |
STOCH | 83.333▲ | 60.796 | 37.358 | 51.365 | 26.050 |
WILL %R | -77.778▼ | -57.895 | -57.895 | -31.627 | -66.981 |
CCI | -51.667 | 56.767 | 28.480 | 28.483 | -75.603 |
Monday, May 13, 2024 09:19 AM
Baird raised the price target for the Coherus Biosciences Inc (NASDAQ:CHRS) stock to “an Outperform”. The rating was released on November 17, 2023, according to finviz. The research report from ...
|
Sunday, May 12, 2024 04:34 PM
A multi-industry industrial company, an aerospace supplier, and a building materials company all look like good values now.
|
Friday, May 10, 2024 01:45 PM
Q1 2024 Earnings Call Transcript. CHRS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 2.17 | 2.215 | 2.12 | 2.16 | 1,249,237 |
15/05/24 | 2.09 | 2.23 | 2.09 | 2.18 | 2,475,129 |
14/05/24 | 2.04 | 2.1951 | 2.00 | 2.08 | 2,201,171 |
13/05/24 | 2.07 | 2.17 | 2.005 | 2.08 | 3,629,033 |
10/05/24 | 2.17 | 2.18 | 1.81 | 1.90 | 5,242,224 |
09/05/24 | 2.25 | 2.27 | 2.11 | 2.12 | 2,203,793 |
08/05/24 | 2.25 | 2.28 | 2.18 | 2.23 | 1,247,098 |
07/05/24 | 2.22 | 2.27 | 2.19 | 2.25 | 656,324 |
06/05/24 | 2.27 | 2.32 | 2.15 | 2.22 | 1,302,068 |
03/05/24 | 2.20 | 2.3219 | 2.19 | 2.27 | 1,527,524 |
|
|
||||
|
|
||||
|
|